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Abstract
Background: Fascin is a globular actin cross-linking protein, which plays a major role in forming parallel actin
bundles in cell protrusions and is found to be associated with tumor cell invasion and metastasis in various type of
cancers including oral squamous cell carcinoma (OSCC). Previously, we have demonstrated that fascin regulates
actin polymerization and thereby promotes cell motility in K8-depleted OSCC cells. In the present study we have
investigated the role of fascin in tumor progression of OSCC.
Methods: To understand the role of fascin in OSCC development and/or progression, fascin was overexpressed
along with vector control in OSCC derived cells AW13516. The phenotype was studied using wound healing,
Boyden chamber, cell adhesion, Hanging drop, soft agar and tumorigenicity assays. Further, fascin expression was
examined in human OSCC samples (N = 131) using immunohistochemistry and level of its expression was
correlated with clinico-pathological parameters of the patients.
Results: Fascin overexpression in OSCC derived cells led to significant increase in cell migration, cell invasion and
MMP-2 activity. In addition these cells demonstrated increased levels of phosphorylated AKT, ERK1/2 and JNK1/2.
Our in vitro results were consistent with correlative studies of fascin expression with the clinico-pathological
parameters of the OSCC patients. Fascin expression in OSCC showed statistically significant correlation with
increased tumor stage (P = 0.041), increased lymph node metastasis (P = 0.001), less differentiation (P = 0.005),
increased recurrence (P = 0.038) and shorter survival (P = 0.004) of the patients.
Conclusion: In conclusion, our results indicate that fascin promotes tumor progression and activates AKT and
MAPK pathways in OSCC-derived cells. Further, our correlative studies of fascin expression in OSCC with clinico-
pathological parameters of the patients indicate that fascin may prove to be useful in prognostication and
treatment of OSCC.
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Background
Oral squamous cell carcinoma (OSCC) is the sixth most
common malignancy in the world and ranks as the first
in males in the Indian subcontinent. It is a major cause
of cancer morbidity and mortality [1]. Unfortunately,
despite the advancements in surgery, chemotherapy,
radiation and other combinational therapies, only 60%
of affected individuals survive for 5 years [2,3]. Local
recurrence and regional lymph node metastasis are two
major hurdles in the management of the advanced stage
OSCC [4-6]. Thus a comprehensive investigation of the
factors and molecular events which contribute to local
recurrence and invasion of OSCC are necessary for the
development of novel strategies for prognostication and
treatment.
Metastatic and invasive tumor cells often exhibit
changes in cell morphology, disruption of cell-cell con-
tacts, degradation of ECM and increase in cell migra-
tion, which result from rearrangements of the
cytoskeletal microfilaments. Reorganization of the actin
* Correspondence: mvaidya@actrec.gov.in
1Advanced Centre for Treatment Research and Education in Cancer Tata
Memorial Centre (ACTREC), Kharghar, Navi Mumbai, India-410210
Full list of author information is available at the end of the article
Alam et al. BMC Cancer 2012, 12:32
http://www.biomedcentral.com/1471-2407/12/32
© 2012 Alam et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.cytoskeleton is regulated by the action of actin cross-
linking proteins. Fascin is a highly conserved 55-kDa
actin bundling protein that plays an important role in
the organization of several types of actin-based struc-
tures such as filopodia, lamellipodial ribs, dendrites,
spikes and microvilli [7]. It was first detected in the
extracts of unfertilized sea urchin eggs and localized
within microvilli and filopodia of fertilized sea urchin
eggs [8]. Fascin is predominantly expressed in cells
which form membrane protrusions and require motility,
such as neurons, glial cells and dendritic cells [9-11]
and also in migrating cells such as endothelial cells and
macrophages [11]. Fascin expression is either low or
absent in adult epithelia and is often upregulated in sev-
eral types of epithelial cancers [12] including breast
[13,14], ovary [15], skin [16], pancreas, liver cancer etc.
[17-19]. High expression of fascin has also been
reported in OSCC. Fascin is also found to be involved
in formation of invadopodia and appears to aid tumor
cell invasion [20]. A number of prior studies have
shown that fascin upregulation is associated with a
more aggressive and metastatic phenotype in epithelial
cancers [12,21-27]. Although, several correlative studies
have demonstrated tumor promoting function of fascin,
its role in tumor development and/or progression of
OSCC has not been comprehensively investigated yet.
We have previously reported that fascin regulates
actin polymerization and cell motility in K8-knockdown
OSCC cells. Decrease in fascin levels was also associated
with reduced invasive ability and tumorigenicity in K8-
depleted cells [28]. In the present communication, we
have demonstrated the role of fascin in cell migration,
invasion and tumorigenicity in fascin overexpressed-
OSCC-derived cell line. Further, we show a higher
expression of fascin in tissue samples of OSCC using
IHC analysis, which correlated with clinico-pathological
parameters of the patients such as tumor stage, lymph
node metastasis and survival.
Methods
Cell lines, plasmids, transfection, western blotting and
immunofluorescence staining
The cell line AW13516 derived from the SCC of ton-
gue was cultured as described previously [28]. The fas-
cin overexpressed clones were selected in 1000 μg/ml
G418 sulphate, from AW13516 cells by transfecting 2
μgo fG F Pt a g g e df a s c i n( ak i n dg i f tf r o mD r .JA d a m s ,
USA), or the empty vector, using liposome based
FUGENE HD transfection reagent (Roche; according to
manufacturer’s protocol). Stable clones were screened
for the overexpression of fascin by laser confocal
microscopy and western blot analysis as described pre-
viously [29].
Antibodies and reagents
The following antibodies were used -Keratin8 and b-
actin (Sigma), b4-integrin, Akt and p38 (Santa Cruz),
phospho-JNK1/2, JNK1/2, phospho-FAK, phospho-p38
and FAK (Cell Signalling), fascin, b-catenin, phospho-
Akt, phospho-ERK1/2, and ERK1/2 (Abcam), E-cadherin
and PCNA (BD Biosciences), secondary antibodies- HRP
conjugated anti-mouse and anti-rabbit (Amarsham),
Alexa 488-conjugated anti-mouse IgG and Alexa 568-
conjugated anti-rabbit IgG (Molecular Probes). TRITC
conjugated phalloidin (Sigma) was used to analyze fila-
mentous actin according to the manufacturer’s
instructions.
Cell proliferation assay (MTT assay)
Proliferation rate was determined by taking OD every 24
h up to a period of 5 days using MTT assay as described
previously [30].
Hanging drop assay
Hanging drop assay was performed to estimate the cell-
cell adhesive properties of the fascin-overexpressed cells
compared to the vector control clones as described pre-
v i o u s l y[ 3 1 ] .B r i e f l y ,2×1 0
4 cells were suspended in 35
μl drops of complete medium from the lid of 24-well
plate for 16 h. Images of cell aggregates of five random
fields from three different suspensions were captured
with an upright AxioImager. Z1 microscope (Carl Zeiss,
Germany) for each sample. The area of cell aggregates
was determined using the Axiovision rel 4.5 software
(Zeiss).
Cell adhesion assay
96 well flat bottom plates coated with 50 μl/well of
ECM substrates (Matrigel: 10 μg / m l ,F i b r o n e c t i n :2 . 5
μg/ml, Collagen type IV: 10 μg/ml, Laminin: 5 μg/ml in
PBS) and cell-ECM adhesion assay was carried out as
described previously [32].
Zymography
To determine the Matrix Metalloproteinase (MMP)
activity in conditioned culture medium, gelatin zymogra-
phy was performed as described previously [33]. The
position of the MMPs was visualized by staining the
gels in Coomassie Brilliant Blue G-250 solution [33].
Tumorigenicity, invasion and wound-healing assay
Soft agar assay and tumor formation in SCID mice was
performed as described previously [28]. Five animals
were used for each group. The ellipsoid volume formula
1/2 × L × W × H was used to calculate the tumor
volume. The invasiveness was determined by Boyden
chamber invasion assay as described previously [32].
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4 cells in 200 μl of cell suspension were
charged on to the insert and the plates were incubated
for 40 h at 37°C. Post incubation the total number of
cells was counted in 4-5 different fields. Data obtained
from three separate chambers were shown as mean
values. Wound-healing assay was performed as
described previously [28]. Briefly, the cells were grown
in 35 mm plates upto 80% confluency and were replaced
with serum free medium to inhibit cell proliferation.
After 16 h of serum starvation, wounds were scratched
with the help of sterile 2 μl pipette tip. The wound heal-
ings were observed by time lapse microscopy, and
images were taken every 10’ for 12 h. Migration was
measured using Axiovision software version 4.5 (Zeiss).
Surgical specimens and clinico-pathological records of
the patients
A total of 131 paraffin embeded blocks of oral SCC [71
SCC of tongue (TSCC) and 60 SCC of buccal mucosa
(BMSCC)] tissues were collected from the Tata Mem-
orial Hospital (TMH), Parel, Mumbai, India. Six OSCC
tissues (primary tumors as well as lymph nodes) of
patients showing lymph node metastasis were collected
from operation theatre of TMH at the time of surgery.
Five punch biopsy samples of patients suffering from
inflammatory fibrous hyperplasia of oral cavity (2 BM
and 3 Gingival) were obtained from Nair Dental Col-
lege, Mumbai, India as controls. The patients had no
history of malignancy. This study was approved by the
Human Ethics Committees of the respective Institu-
tional Review Boards. Informed consent was obtained
from the patients as well as healthy individuals. Clin-
ico-pathological information was collected from the
clinical and pathology records of TMH (Additional file
1: Table S1).
Histology, immunohistochemistry (IHC) and
immunofluorescence (IF)
Tissue samples were fixed in 10% formalin buffer and
five micron sections were cut from paraffin embedded
blocks. Sections were stained with hematoxylin/eosin for
histological diagnosis. Immunohistochemical staining
was performed using Elite ABC Kit (Vector laboratories;
USA) as described earlier [34]. The primary antibodies,
fascin (mouse anti-human; Abcam), K8 (mouse anti-
human; Sigma) and b4-integrin (rabbit anti-human; San-
tacruz Biotechnology) were used at dilutions of 1:100,
1:200 and 1:100 respectively. Specimens for fascin, K8
and b4-integrin immunostaining were divided into three
categories: High (homogenous positive tumor in more
than 50% of cells or/and high membranous and cyto-
plasmic staining in more than 50% of cells; ++/+++);
low (20-50% positive tumor cells; +); negative (less than
20% positive cells or no evidence of staining; -). Results
of IHC were independently assessed by two observers.
For immunofluorescence staining Alexa 488-conjugated
anti-mouse IgG (1:200) and Alexa 568-conjugated anti-
rabbit IgG (1:200) were used as secondary antibodies.
T h et i s s u es e c t i o n sw e r em o u n t e du s i n gV E C T A -
SHEILD mounting medium (Vector Laboratories).
Images were captured using laser confocal microscopy.
Statistical analysis
Statistical analysis of the clinical samples was carried out
using SPSS software. To assess correlations between
clinico-pathological parameters and proteins expression,
the Chi Square test was used. Univariant analysis was
performed using the Kaplan-Meier method and statisti-
cal significance between survival curves was assessed by
the log rank tests. The data were analyzed with the Sta-
tistical Package, SPSS 16.0 for Windows (SPSS Inc., Chi-
cago, IL, USA) [34]. Two groups of data were
statistically analyzed by tt e s tusing Graphpad Prism5
Software. A p value less than 0.05 was considered statis-
tically significant.
Results
Fascin overexpression leads to alterations in cell
morphology and actin organization
In order to understand the role of fascin in progression
of OSCC, GFP tagged fascin or pEGFP empty vector
was stably-overexpressed in OSCC derived cell line
AW13516. Stable over expression of exogenous fascin
and GFP was checked by western blotting and confocal
microscopy (Figure 1A, B). Exogenous fascin was found
to be localized on the cell membrane as well as in the
cytoplasm. Membranous fascin appeared mostly in the
form of microspikes and intermittently was present on
the edges of the cell membrane (Figure 1B). Morpholo-
gical alterations like increase in membrane protrusions
and disorganization of cell-cell contacts were observed
by phase contrast microscopy in fascin-overexpressed
cells. (Additional file 2: Figure S1A). Further, to deter-
mine the effect of fascin overexpression on organization
of actin cytoskeleton, these cells were stained with
TRITC-labelled phalloidin and were analyzed by confo-
cal microscopy. Fascin overexpressing clones AW-Fas-
cin-1 and AW-Fascin-2 demonstrated dramatic increase
in membrane protrusions like filopodia and lamellipodia
compared to the vector control clone AW-GFP-Cont
(Figure 1C, D). In addition, exogenous fascin was found
to be co-localized with F-actin at mostly at membrane
protrusions and filopodia (Figure 1A). These results
together indicate that fascin overexpression leads to
increase in F-actin based structures like filopodia and
lamellipodia. The changes observed in actin reorganiza-
tion also correlated well with morphological alterations
exhibited by fascin overexpressed cells.
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invasion and matrix metalloproteinase activity
To determine if the alterations in actin organization and
morphology upon fascin overexpression led to changes
in cell migration and invasion, scratch wound healing
assay and Boyden chamber invasion assay were
performed respectively (Figure 2A). Fascin overex-
pressed clones (AW-Fascin-1and AW-Fascin-2) showed
more than two fold increase in cell migration rate com-
pared to vector control (AW-GFP-Cont.) clone (P <
0.05; Figure 2B). These cells also demonstrated signifi-
cant increase in invasive ability as compared to vector
Figure 1 Overexpression of fascin leads to reorganization of actin cytoskeleton.( A) Western blot and confocal analysis of stable
overexpression of Fascin-GFP (AW-Fascin-1 and AW-Fascin-2) and empty vector control pEGFP (AW-GFP-Cont) clones derived from AW13516
cells with antibodies to GFP and fascin. b-actin was used as loading control. Scale bars: 10 μm. (B) Representative confocal images of stably
expressed GFP tagged fascin and GFP alone in AW-Fascin-1, AW-Fascin-2 and AW-GFP-Cont clones respectively. Cells were counter stained with
DAPI. Scale bars: 10 μm. Arrow heads and arrows indicate filopodia and lamellipodia respectively. (C) Representative confocal images of F-actin
stained with phalloidin-TRITC and the co-localization of F-actin with Fascin-GFP in stable AW-Fascin-1, AW-Fascin-2 and AW-GFP-Cont clones.
Cells were counter stained with DAPI. Scale bars: 10 μm. Arrows indicate colocalization of Fascin-GFP with F-actin at filopodia like structures. (D)
Histogram showing number of filopodia formed by fascin overexpressed (AW-Fascin-1 and AW-Fascin-2) and vector control (AW-GFP-Cont) cells.
Mean and standard deviation of 3 independent experiments is plotted (p < 0.0001). (E) Histogram showing number of lamellipodia formed by
fascin overexpressed (AW-Fascin-1 and AW-Fascin-2) and vector control (AW-GFP-Cont) cells. Mean and standard deviation of 3 independent
experiments is plotted (p < 0.0001)
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of our gelatin zymography experiments showed that fas-
cin overexpressed clones secreted more MMP2 com-
pared to control cells (Figure 2D). These data together
suggest that, increase in filopodia formation and actin
reorganization upon fascin overexpression is associated
with an increase in migratory and invasive ability of
these cells.
Fascin overexpression resulted in increased cell-ECM
adhesion and loss of cell-cell contacts
Since filopodia have an important role to play in cell-
ECM adhesion, we checked whether fascin overexpres-
sion affects OSCC cell adhesion. Fascin-overexpressed
clones demonstrated significant increase in adhesion to
different ECM substrates such as matrigel, collagen,
laminin and fibronectin in comparison with vector con-
trol cells (Figure 3A). We did not observe any consider-
able change in a6a n db4 integrin levels upon fascin
overexpression. There was no considerable change in
the levels of phosphorylated FAK in fascin overex-
pressed cells (Figure 3B).
Our observations using phase contrast microscopy
suggest that fascin overexpression in the cells may
result in loss of cell-cell contacts. In order to confirm
this observation, hanging drop assay was performed.
The fascin overexpressed clones formed smaller
aggregates compared to the vector control clone
which indicates that fascin overexpression leads to
loss of cell-cell contacts (P < 0.0001) (Figure 3C, D;
Additional file 3: Table S2). Further, we examined
whether the level of expression of b-catenin and E-
Figure 2 Overexpression of fascin leads to increase in cell migration, invasion and MMPs activity.( A and B) Phase contrast images
(magnification 10×) of wound closure at 0 h, 6 h and 12 h of the vector control (AW-GFP-Cont) and fascin overexpressed clones (AW-Fascin-1
and AW-Fascin-2) are shown in the figure. Scale bar: 100 μm. The data shown is the average migration rate from three independent experiments
with the mean and standard deviation (p < 0.05). (C) Boyden chamber invasion assay of vector control (AW-GFP-Cont) and fascin overexpressed
clones (AW-Fascin-1 and AW-Fascin-2). The data shown is the average from three independent experiments with the mean and standard
deviation (p < 0.01). (D) Zymogram showing MMP-2 activity in vector control (AWGFP-Cont) and fascin overexpressed (AW-Fascin-1 and AW-
Fascin-2) cells.
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using western blot analysis. There was significant
r e d u c t i o ni nE - c a d h e r i na n db-catenin levels in these
cells. We also observed colocalization of b-catenin
with fascin in fascin overexpressing cells (Figure 3E,
F) and reduction in their levels at the cell surface
(Additional file 2: Figure S1C) as analyzed by confocal
microscopy.
Figure 3 Fascin overexpressed cells demonstrated increase in cell-ECM adhesion and loss of cell-cell contacts.( A) Cell adhesion of
fascin-overexpressed (AW-Fascin-1 and AW-Fascin-2) and vector control (AW-GFP-Cont) cells to different ECM substrates was measured as
described. The data shown is the average from three experiments with the mean and standard deviation. (B) Western blot analysis of stable
fascin-overexpressed (AW-Fascin-1 and AW-Fascin-2) and vector control (AW-GFP-Cont) clones with antibodies to a6 integrin, b4 integrin and
phosphorylated FAK. b-actin and total FAK were used as internal loading controls respectively. (C) Representative images of aggregates formed
by of fascin overexpressed (AW-Fascin-1 and AW-Fascin-2) and vector control (AW-GFP-Cont) cells in hanging drop assay. (D) Histogram showing
size of aggregates formed by overexpressed (AW-Fascin-1 and AW-Fascin-2) and vector control (AW-GFP-Cont) cells. Mean and standard
deviation of 3 independent experiments is plotted (p < 0.0001). (E) Confocal analysis of E-cadherin and b-catenin localization in fascin
overexpressed cells. Scale bars; 10 μm. (F) Western blot analysis of fascin overexpressed (AW-Fascin-1 and AW-Fascin-2) and vector control clones
(AW-GFP-Cont) with antibodies to E-cadherin and b-catenin. b-actin was used as a loading control. (G) RT-PCR analysis of snail, slug and
vimentin overexpressed (AW-Fascin-1 and AW-Fascin-2) and vector control (AW-GFP-Cont) cells. GAPDH was used as internal control.
Alam et al. BMC Cancer 2012, 12:32
http://www.biomedcentral.com/1471-2407/12/32
Page 6 of 15Since fascin overexpressed cells showed significant
increase in cell migration, invasion and substantial
reduction in E-cadherin levels which are known to be
associated with EMT, we also determined the levels of
EMT markers such as snail, slug and vimentin using
RT-PCR analysis. Fascin overexpressed cells did not
show any increase in these markers (Figure 3G). Further,
we also analyzed the protein levels of vimentin in these
clones by western blot analysis. There was no significant
difference observed at the protein levels of vimentin
between these clones (Additional file 2: Figure S1B).
These results indicate that overexpression of fascin led
to increase in cell-ECM adhesion and loss of cell-cell
contacts.
Fascin overexpression leads to increase in tumorigenicity
both in vitro and in vivo
To determine the effect of fascin expression on tumori-
genicity in vitro and in vivo, anchorage-independent
growth and tumor formation in SCID mice was studied.
The fascin-overexpressed clones (AW-Fascin-1 and
AW-Fascin-2) demonstrated significant increase in num-
ber (Figure 4A) and size of colonies formed in soft agar
compared to AW-GFP-Cont after 14 days (P <0 . 0 1 )
(Additional file 2: Figure S1D). We compared the
growth of subcutaneous xenografts of fascin-overex-
pressed clones and vector control clone in NOD-SCID
mice for 10 weeks. Both AW-Fascin-1 and AW-Fascin-2
clones showed considerable increase in tumor volume
compared to AW-GFP-Cont clone after 10 weeks (P =
0.06) (Figure 4B).
Fascin overexpression leads to increase cell proliferation
and upregulation of MAP kinase and AKT pathways
To check the effect of fascin expression on cell prolif-
eration, cell proliferation rate of fascin overexpressed
and vector control cells was analyzed by MTT asaay.
Fascin-overexpressed cells showed significant increase in
cell proliferation as compared to vector control cells
(Figure 4C). Furthermore, we observed substantial
increase in cell proliferation marker PCNA using wes-
tern blot analysis (Figure 4D). To determine whether
the overexpression of fascin modulates cell proliferation
and/or oncogenic signalling pathways, some central reg-
ulatory molecules of MAP kinase and PI3K signalling
pathways were examined in these cells using western
blot analysis. A significant increase was observed in the
levels of phosphorylation of both ERK1/2 and JNK1/2 in
the fascin overexpressed cells (MAP kinase signalling
pathway) using western blot analysis (Figure 4E). Fascin
overexpressed cells also demonstrated enhanced phos-
phorylation of Akt compared to vector control cells
(PI3K signalling pathway) (Figure 4D). We also analyzed
the phosphorylation levels of p38 in these cells and no
change was observed in the levels of phosphorylated
p38. The increased phosphorylation of ERK1/2, JNK1/2
and Akt correlated with the increased cell proliferation,
motility and tumorigenicity upon fascin overexpression.
Expression of fascin in human OSCC samples
Fascin expression was analyzed in 131 OSCC tissue
samples using semi-quantitative IHC analysis. Out of
131 samples studied, 43 (32.28%) samples showed
intense fascin staining, 55 (41.98%) showed weak stain-
ing of fascin and it was not detected in 33 (25.19%)
samples (Table 1). Fascin staining was observed both in
cytoplasm and cell membrane (Additional file 4: Figure
S2A). Fascin expression was also analyzed in 5 samples
obtained from oral mucosa showing only inflammatory
changes. Weak or negative staining of fascin was seen in
these samples (Additional file 4: Figure S2B). We have
also confirmed the expression of fascin in normal as
well as tumor tissues using immunofluorescence staining
followed by laser confocal analysis (Additional file 5:
Figure S3).
Correlation of fascin expression with clinico-pathological
parameters of the patients
To evaluate the significance of fascin expression in
OSCC, we investigated the correlation between fascin
immunostaining with clinico-pathological parameters of
the patients using Chi Square test. Higher fascin expres-
sion significantly correlated with lymph node metastasis
(P =0 . 0 0 1 ) ,s t a g e( P = 0.041) and differentiation status
(P = 0.005) (Figure. 5A, B; Table 1). Its expression
showed no correlation with other parameters (Addi-
tional file 3: Table S2). In order to check whether fascin
expression was also seen in lymph node showing tumor
metastasis, we have analyzed fascin expression in 6 pri-
mary tumors and lymph node obtained from same
patient using IHC and IF analysis. Fascin staining was
seen in all the primary tumors and corresponding
lymph nodes (Figure 5C; Additional file 6: Figure S4).
Kaplan-Meier survival analysis was conducted to
establish correlation between fascin expression and
patient’s survival. Overall fascin expression showed
negative correlation with patient’s survival. Thus higher
fascin expression showed inverse correlation with
patient’s survival (Figure 6A; P = 0.025), while low or no
fascin expression indicated better survival rate (Figure
6B; P = 0.004). In addition, fascin expression signifi-
cantly correlated with increased recurrence rate (Figure
6D; P = 0.038) and shorter disease free survival (Figure
6C; P = 0.013).
In our previous study we have found downregulation
of fascin and b4-integrin expression in response to K8
knockdown in OSCC cells [28]. Therefore, we have also
analyzed K8 (n = 131) and b4-integrin (n = 123)
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tried to find out association of these molecules with
clinico-pathological parameters of the patients in combi-
nation (Additional file 4: Figure S2; Additional file 7:
Table S3). Fascin and b4-integrin expression together
correlated with lymph node metastasis (P = 0.001), stage
(P = 0.032) and perineural extension (P = 0.028) (Addi-
tional file 7: Table S3) while fascin and K8 expression
together correlated with tumor stage (P = 0.020), differ-
entiation (P = 0.001), lymph node metastasis (P =
0.002), recurrence (P = 0.004) (Additional file 7: Table
S3). Fascin together with K8 or b4-integrin did not
show any correlation with overall/disease free survival of
the patients (data not shown).
In summary, our in vitro data demonstrated that fas-
cin overexpression in OSCC derived cells led to increase
in cell membrane protrusions, disorganization of cell-
cell contacts and alterations in actin cytoskeleton. These
cells also showed increased cell-ECM adhesion, cell
migration, invasion, and tumorigenicity. In addition, fas-
cin-overexpressed cells demonstrated activation of Akt
and MAP kinase. Furthermore, fascin expression signifi-
cantly correlated with lymph node metastasis, stage and
differentiation status in OSCC samples. Fascin expres-
sion also associated with poor patient survival.
Discussion
Understanding the molecular basis of OSCC progression
especially invasion and metastasis and identification of
potential molecular markers that are contributing to
these processes is required to improve the prognosis
and the survival of the patients. Invasive and metastatic
potential of tumor cells is often associated with reorga-
nization of actin cytoskeleton. Fascin is one such actin
Figure 4 Fascin overexpression resulted in increase in cell proliferation and tumorigenicity.( A) Histogram showing the total number of
colonies formed per plate by the indicated clones after 14 days. Mean and standard deviation of three independent experiments is plotted (p <
0.01). (B) Tumor growth of fascin-overexpressed clones (AW-Fascin-1, AW-Fascin-2) or the vector control (AW-GFP-Cont) was plotted against time
interval. (C) Cell proliferation curves of fascin-overexpressed (AW-Fascin-1 and AW-Fascin-2) and vector control (AW-GFP-Cont) cells using MTT
assay. The cell number was determined at the times indicated. Each point represents the mean and the standard errors of three independent
experiments done in triplicate. (D and E) Western blot analysis of stable fascin-overexpressed (AW-Fascin-1 and AW-Fascin-2) and vector control
(AW-GFP-Cont) clones with antibodies to PCNA and phosphorylated forms of Akt, ERK1/2, JNK1/2 and p38. Total Akt, ERK1/2, JNK1/2, p38 and b-
actin were used as internal loading controls respectively.
Alam et al. BMC Cancer 2012, 12:32
http://www.biomedcentral.com/1471-2407/12/32
Page 8 of 15bundling protein, found to be up-regulated in several
epithelial malignancies including SCC. Its expression has
been correlated with aggressiveness of the tumors [12].
In the present study we have investigated the role of fas-
cin in cell motility, invasion and tumorigenicity using in
v i t r oa n dx e n o g r a f ti nv i v om o u s em o d e l .W eh a v e
further tried to understand the clinical significance of
fascin expression in prognostication of OSCC patients
using IHC analysis of tumor tissues.
The fascin-overexpressed OSCC cells formed longer
and thicker microspikes, develop more filopodia and
lamellipodia (Figure 1), and showed significant increase
in cell motility (Figure 2A, B). Several prior studies have
shown that fascin overexpression induce lamellipodia
and filopodia formation and enhances cell migratory
ability in different cell types [35-37]. These fascin-over-
expressed cells also showed disorganization of cell-cell
contacts (Figure 3C, D), decrease in E-cadherin and b-
catenin levels (Figure 3F). Previously it has been shown
that fascin overexpression led to disorganization of cell-
cell contacts and reduction in E-cadherin and b-catenin
levels in epithelial cells [37]. The observed reduction in
total b-catenin levels may be due to loss of cell-cell con-
tacts which intern may lead to its degradation at cell
surface (Additional file 2: Figure S1C). Previous reports
have also shown reduction or loss of total and/or cell
surface levels of b-catenin in OSCC samples and corre-
lated it with aggressiveness of the tumor and poor prog-
nosis [38-40]. Importantly, the anchorage-independent
growth and xenograft tumor experiments in NOD-SCID
mice indicated that fascin also contributes to the devel-
opment of primary tumors in OSCC (Figure 5A, B). To
our knowledge this is the first report showing the role
of fascin in primary tumor development in OSCC.
These results are consistent with the previous reports
on colon cancer and oesophageal SCC cells [41,42]. Our
results further demonstrated significant increase in inva-
sive potential (Figure 2C) in fascin overexpressed cells.
Previously, fascin has been shown to promote invasive-
ness of the colon, breast and esophageal carcinoma
derived cells [22,43,44]. Chen et al. have identified
migrastatin analogues which inhibit tumor cell migra-
tion, invasion and metastasis by blocking fascin activity
using in vitro as well as in vivo model system in breast
cancer [45]. Furthermore, fascin-overexpressed cells also
demonstrated increase in MMP-2 activity (Figure 2D).
MMP-2 and MMP-9 are proteolytic enzymes that digest
the components of the basement membrane facilitating
metastasis of malignant tumors [46]. Our results are
consistent with Xie et al. findings and suggest that,
increase in MMP-2 activity in response to fascin upre-
gulation would also contribute to increased invasive
Table 1 Correlation of fascin expression with clinico-pathological parameters of the OSCC patients.
Clinico-pathological parameter FASCIN
n(131),% EXPERSSION P-value
Negative Low High
Age (Years) < 50 75 (57.25) 15 30 30 0.091*
≥50 56 (42.75) 18 25 13
Sex Male 102 (77.87) 25 41 36 0.524*
Female 29 (22.14) 8 14 7
Location Tongue 61 (46.56) 17 27 26 0.517*
BM 70 (53.44) 16 28 17
Thickness < 2 cm 92 (70.23) 25 35 32 0.370*
≥2 cm 39 (29.77) 8 20 11
Stages I/II 28 (21.38) 9 15 4 0.041
#
III/IV 103 (78.62) 24 40 39
Tumor Size T1/T2 48 (36.65) 13 23 12 0.254
#
T3/T4 83 (63.35) 20 31 32
Node Status NO 47 (35.88) 17 22 8 0.001
#
N1 34 (25.95) 8 14 12
N2 50 (38.17) 8 19 23
Differentiation Poor + Moderate 124 (94.65) 28 53 43 0.005
#
well 7 (5.34) 5 2 0
Perineural Extension Yes 55 (41.98) 11 22 22 0.538*
No 62 (47.33) 16 27 19
* Pearson Chi-Square;
# Spearman Correlation (Ordinal by Ordinal)
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Page 9 of 15Figure 5 IHC analysis of fascin levels in human OSCC tissues.( A) Representative images of immunohistochemical staining with antibodies
against fascin of paraffin embedded sections of normal different lymph-node metastasis and stage of human OSCC tissues. Sections were
counter stained with eosin (Magnification: 200×). (B) Histograms showing correlation of fascin expression with clinico-pathological parameters
such as differentiation, lymph-node metastasis and tumor stage of OSCC patients. (C) Representative images of immunofluoroscence staining
with antibodies against fascin of paraffin embedded sections of lymph-node metastasized tumor of human OSCC tissues. Sections were counter
stained with DAPI. Scale bars: 50 μm.
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Page 10 of 15ability of the carcinoma cells [42]. Thus, our results
indicate that fascin overexpression leads to increase in
cell motility, tumorigenicity and invasive potential of
OSCC cells.
Increased cell migration, invasion, tumorigenicity and
loss of E-cadherin expression are often observed during
Epithelial Mesenchymal Transition (EMT) [47]. Here
fascin overexpressed cells did not show any increase in
EMT markers such as snail, slug and vimentin (Figure
3G; Additional file 2: Figure S1B). Our results are in
agreement with the previous report, in which Vignjevic
et al. have shown that fascin mediated tumor cell migra-
tion and invasion did not involve EMT in human colon
cancer [48]. These results together suggest that fascin
may promote cell migration and invasion of tumor cells
through collective cell migration by filopodia formation
[49] in OSCC.
Interactions between cells and their extracellular
matrix play an important role in tissue organisation and
also influence many aspects of cell behaviour including
cell shape and cell migration [50-52]. During cell migra-
tion, Thrombpspondin-1 induces cross-linking of fascin
and F-actin that leads to formation of F-actin based cell
protrusions. Fibronectin triggers phosphorylation of fas-
cin at S39, leading to rapid loss of fascin from actin-
based structures during initial cell spreading, in a protein
kinase Ca (PKCa)-dependent process [53,54]. Here, fascin
overexpression facilitated cell adhesion to fibronectin,
laminin and other ECM molecules in OSCC cells. Pre-
viously, it has been shown that fascin may be involved in
cell-ECM interaction through integrin [55]. Previous
reports also suggest that fascin regulates focal adhesion
disassembly and activation of FAK [56]. We did not
observe any consistent change in a6-integrin, b4-integrin
and phosphorylated FAK levels in all the fascin overex-
pressed clones (Figure 3B). This suggests that a6b4-
integrin-FAK-mediated signalling may not be involved in
fascin dependent cell-ECM interaction in OSCC.
Overexpression of fascin is often associated with
increased cell proliferation in different types of
Figure 6 Correlation of fascin expression with survival rate of OSCC patients using Kaplan-Meier analysis. (A and B) Analysis of overall
survival in OSCC patients and fascin expression (fascin expression is either negative or positive; *, p < 0.025), (fascin expression is negative, low
or high; *, p < 0.004) (C) Analysis of disease free survival times of OSCC patients and fascin (fascin expression is either negative or positive; **, p
< 0.013) expression. (D) Histogram showing percentage of recurrence in fascin positive samples of OSCC patients.
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Page 11 of 15carcinomas [42,43,57]. Our results have shown increase
in cell proliferation in response to fascin overexpression
which was accompanied with increased cell proliferation
marker PCNA (Figure 4D). In addition, upregulation of
PI3K and MAP kinase pathways was also observed in
fascin-overexpressed cells (Figure 4D, E). PI3-K and
MAP kinase pathways are independently known to regu-
late cell proliferation and migration in epithelial cells
and upregulation of these signalling pathways has been
documented in carcinomas including OSCC [58-60].
Further, the role of MAPKs in the regulation of MMP
expression in carcinoma cells has also been well-studied
[61]. It has been shown that inhibition of p-ERK1/2 may
lead to a reduction in the expression of MMP-2 and
invasive ability of tumor cells [62,63]. These results sug-
gest that fascin possibly regulates MMPs activity and
invasiveness through MAPKs pathway. Previously it has
been reported that Akt activation is a significant prog-
nostic indicator for OSCC [64]. Taken together our
results suggest that apart from regulating actin polymer-
ization and thereby cell motility, fascin may also activate
PI3K and MAP kinase signalling pathways in tumor
cells. These events subsequently promote tumor
progression.
Next we investigated the clinical significance of fascin
expression in prognostication of OSCC patients. Correla-
tion of fascin expression with lymph node metastasis and
its presence (Figure 5; Table 1) in lymph node tissues
showing tumor metastasis (Figure 5C) suggest that fascin
may facilitate movement of tumor cells from the primary
site to the lymph node. Lymph node metastasis is widely
accepted as one of the major prognostic factors in OSCC
patients and it’s presence is associated with a decrease in
overall survival and higher recurrence rates [6,65-68].
High fascin expression was seen in 17% cases where
lymph node metastasis was not detected (N0). It will be
interesting to follow these cases further to understand
whether fascin expression is indicative of “submicro-
scopic” occult metastasis which is known to have impact
on patient survival [65,67,69]. Furthermore, fascin
expression was not detected in any of the well differen-
tiated OSCC (Figure 5B; Table 1) and higher fascin
expression was mostly found in higher stage tumors (Fig-
ure 5A, B; Table 1). A large number of studies have
demonstrated that disease staging has a crucial influence
on the outcome [66,70]. A number of studies have also
shown significant correlation between lower histologic
differentiation and poorer prognosis [6,66,70]. We were
further able to show correlation between fascin expres-
sion and poor patient survival (Figure 6A, B). On the
other hand fascin non-expression was indicative of dis-
ease free survival and decreased chance of recurrence
(Figure 6C, D). Although, Chen et al. have demonstrated
correlation of fascin levels with tumor size, lymph node
metastasis and staging, they have not reported correlation
study with survival of the patients [27]. Lee et al. have
also shown correlation of fascin expression with nodal
metastasis, tumor recurrence and poor patient’ss u r v i v a l
in 49 OSCC samples [27,71]. In this study, we did not
observe correlation of fascin expression with tumor size
but we could show correlation with differentiation status.
Thus apart from confirming the findings of previous stu-
dies on larger sample size, we could show its relation
with disease free survival and confirm its expression in
lymph node metastasis. Thus our results demonstrate
prognostic value of fascin expression in OSCC.
R e c e n t l y ,w eh a v es h o w nt h a tk n o c k d o w no fK 8i na n
OSCC derived cell line resulted in reduced fascin and b4-
integrin levels which correlated with decreased tumori-
genicity, migration and invasiveness of these cells [28].
Therefore, we further analyzed association of fascin in
combination with K8 and b4-integrin expression with
clinico-pathological parameters of the patients. Fascin
and K8 expression together correlated with tumor stage,
differentiation status, lymph node metastasis and recur-
rence while fascin and b4-integrin expression together
correlated with differentiation status, lymph node metas-
tasis and per neural tumor extension (Additional file 7:
Table S3). We did not observe correlation between
expression of all these proteins (fascin, b4-integrin and
K8) together with patient survival (data not shown) possi-
bly because of the smaller sample size. A study with lar-
ger sample size is required to highlight the significance of
their expression together in prognostication of OSCC.
Conclusions
In conclusion, fascin promotes tumor cell progression
and modulates tumor associated signalling pathways
such as Akt and MAP kinase in OSCC. The precise
molecular mechanism of fascin dependent regulation of
Akt and MAPK in OSCC needs further investigation. In
addition, increased fascin levels in human OSCC signifi-
cantly correlated with stage, lymph node metastasis and
poor patient survival. Thus, the current study not only
has identified a novel mechanism of fascin dependent
tumor progression but also illustrated a prognostic value
of fascin in OSCC. Furthermore, actin cytoskeleton
associated protein such as fascin can be explored as new
therapeutic target for human oral cancer. Potential
d r u g ss u c ha sm i g r a s t a t i na n alogues targeting fascin
may prove to be effective in the prevention or treatment
of higher grade and metastatic oral tumors.
Additional material
Additional file 1: Table S1. Clinico-pathological parameters of the OSCC
patients.
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Page 12 of 15Additional file 2: Figure S1. (A) Cell morphology (shape) of fascin-
overexpressed and vector control clone analyzed by phase contrast
microscopy. Scale bar: 100 μm. (B) Western blot analysis of fascin-
overexpressed (AW-Fascin-1 and AW-Fascin-2) and vector control clones
(AW-GFP-Cont) with antibody to vimentin. b-actin was used as a loading
control. (C) Representative confocal images of b-catenin and E-cadherin
staining in stable AW-Fascin-1, AW-Fascin-2 and AW-GFP-Cont clones.
Scale bars: 10 μm. (D) Representative image of the size and number of
colonies formed in soft agar of the indicated clones. Scale bar: 100 μm.
Additional file 3: Table S2. The Fascin overexpressed clones show a
decrease in cell-cell adhesion. Cell adhesion was measured by the
hanging drop assay as described. 2 × 10
4 cells of the indicated clones
were resuspended in 35 μl of complete medium on the lid of a 24 well
dish. 16 h later the cells were fixed and the number and area of
aggregates in fifteen fields was measured. The numbers of aggregates of
different sizes are shown.
Additional file 4: Figure S2. Representative images of haematoxylin
and eosin along with immunohistochemical staining with antibodies
against fascin, K8 and b4-integrin on paraffin embedded sections of
human in oral tumors (A) and non malignant tissues (B). Sections were
counter stained with eosin (Magnification: 200×).
Additional file 5: Figure 3. (A) Representative images of
immunofluorescence staining with antibodies against b4-integrin and K1
of paraffin embedded sections of non malignant oral tissues. Sections
were counter stained with DAPI. Scale bar: 50 μm. (B) Representative
images of immunofluoroscence staining with antibodies against fascin,
b4-integrin and K14 of paraffin embedded sections of human oral
tumors and fascin IF stainging in non malignant oral tissues. Sections
were counter stained with DAPI. Scale bar: 50 μm.
Additional file 6: Figure S4. Representative images of IHC staining with
antibodies against fascin on paraffin embedded sections o f primary
tumor and lymph node metastasized tumor of human OSCC tissues.
Sections were counter stained with eosin (Magnification: 200×).
Additional file 7: Table S3. Correlations of fascin in combination with
K8 and b4-integrin expression with clinico-pathological parameters of the
OSCC patients.
Additional file 8: Figure R1. (A and B)Western blot analysis of fascin-
overexpressed (AW-Fascin-1 and AW-Fascin-2) and vector control clones
(AW-GFP-Cont) with antibodies to a6-integrin, b4-integrin and pFAK. b-
actin and FAK were used as loading control respectively. Densitometric
analysis for the quantification of level of a6-integrin, b4-integrin and
pFAK obtained from western blot of the indicated clones. (C and D)
Western blot analysis of fascin-overexpressed (AW-Fascin-1 and AW-
Fascin-2) and vector control clones (AW-GFP-Cont) with antibodies to
fascin. b-actin was used as a loading control. Quantification of levels of
fascin in fascin-overexpressed (AW-Fascin-1 and AW-Fascin-2) and vector
control (AW-GFP-Cont) clones using densitometric analysis.
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